Sign inJoin Free
DashboardSign out
Clinical Research Coordinator
Full course · Safety Reporting and Pharmacovigilance for CRCs
Clinical Research Coordinator
Full course · Safety Reporting and Pharmacovigilance for CRCs
Free Lesson Preview
Module 1: Lesson 1
Master the CTCAE severity grading framework and protocol-specific grading scales, applying term-specific criteria to common adverse events encountered in clinical trials.
A conceptual hero image depicting the structured assessment of adverse event severity in clinical trials. A graduated scale rises from left to right through five distinct levels, each rendered with increasing visual intensity -- from a faint, barely perceptible mark at Grade 1 through progressively deeper tones to a stark, unambiguous endpoint at Grade 5. Overlaid on the scale, clinical measurement instruments (a thermometer, a blood pressure cuff, a laboratory report) suggest that grading is anchored in objective criteria, not subjective impression. The composition conveys precision: severity grading is a disciplined act of measurement, not a guess.
A participant in a Phase II oncology trial reports nausea at her Week 4 visit. The coordinator writes "mild nausea" in the source document and moves on. But what does "mild" mean here? The participant says the nausea is tolerable -- she can still eat, still go to work. That sounds mild. Yet when the coordinator asks more carefully, it emerges that the participant has been eating only half of her usual meals for the past five days. She has not vomited, but her oral intake is measurably reduced.
Under the Common Terminology Criteria for Adverse Events (CTCAE), this is not Grade 1 nausea. Grade 1 is loss of appetite without alteration of eating habits. Decreased oral intake without significant weight loss or dehydration is Grade 2 -- moderate nausea, the grade that triggers a clinical conversation about whether anti-emetic therapy or dose modification is warranted.
The difference between Grade 1 and Grade 2 here is not academic. It changes the clinical response, the data recorded in the case report form, and potentially the course of the participant's treatment. And the coordinator who wrote "mild" without consulting the CTCAE criteria made a grading error that will persist in the safety database unless someone catches it.
This is, in my view, one of the most underappreciated skills in clinical research coordination: precise severity grading. Module 1 established that severity and seriousness are independent dimensions -- that severity describes intensity while seriousness describes consequence. This lesson takes that conceptual foundation and makes it operational. You will learn the grading system, practice applying it to the adverse events you encounter most frequently, and develop the habit of reaching for criteria rather than impressions.
Free Lesson Preview
Module 1: Lesson 1
Master the CTCAE severity grading framework and protocol-specific grading scales, applying term-specific criteria to common adverse events encountered in clinical trials.
A conceptual hero image depicting the structured assessment of adverse event severity in clinical trials. A graduated scale rises from left to right through five distinct levels, each rendered with increasing visual intensity -- from a faint, barely perceptible mark at Grade 1 through progressively deeper tones to a stark, unambiguous endpoint at Grade 5. Overlaid on the scale, clinical measurement instruments (a thermometer, a blood pressure cuff, a laboratory report) suggest that grading is anchored in objective criteria, not subjective impression. The composition conveys precision: severity grading is a disciplined act of measurement, not a guess.
A participant in a Phase II oncology trial reports nausea at her Week 4 visit. The coordinator writes "mild nausea" in the source document and moves on. But what does "mild" mean here? The participant says the nausea is tolerable -- she can still eat, still go to work. That sounds mild. Yet when the coordinator asks more carefully, it emerges that the participant has been eating only half of her usual meals for the past five days. She has not vomited, but her oral intake is measurably reduced.
Under the Common Terminology Criteria for Adverse Events (CTCAE), this is not Grade 1 nausea. Grade 1 is loss of appetite without alteration of eating habits. Decreased oral intake without significant weight loss or dehydration is Grade 2 -- moderate nausea, the grade that triggers a clinical conversation about whether anti-emetic therapy or dose modification is warranted.
The difference between Grade 1 and Grade 2 here is not academic. It changes the clinical response, the data recorded in the case report form, and potentially the course of the participant's treatment. And the coordinator who wrote "mild" without consulting the CTCAE criteria made a grading error that will persist in the safety database unless someone catches it.
This is, in my view, one of the most underappreciated skills in clinical research coordination: precise severity grading. Module 1 established that severity and seriousness are independent dimensions -- that severity describes intensity while seriousness describes consequence. This lesson takes that conceptual foundation and makes it operational. You will learn the grading system, practice applying it to the adverse events you encounter most frequently, and develop the habit of reaching for criteria rather than impressions.
This is just the beginning
The full CRC track covers 8 courses from study start-up to close-out — the skills sponsors actually look for.
Start the CRC trackThis is just the beginning
The full CRC track covers 8 courses from study start-up to close-out — the skills sponsors actually look for.
Start the CRC track